Skip to content

A clinical evidence based comparison of LM and Centesimal potencies of Homoeopathic medicines in patients suffering with bronchial asthma by checking allergy marker IgE level.

A Comparative Clinical Approach of Homoeopathic Medicine in LM potency and Centesimal potency in the Modulation of Serum IGE levels in patients with Bronchial Asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094857
Enrollment
30
Registered
2025-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: Homoeopathic Medicine in LM Potency.: Individualized homoeopathic remedies prescribed in LM Potency according to symptom similarity, given orally in standard dose and repetition as per

Sponsors

Dr Saumya Srivastava
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases of every age (except children below 6 years of age ) both genders and of different occupations have been included in the study

Exclusion criteria

Exclusion criteria: Patients with acute severe asthma or status asthmaticus,patients with cardiac,pulmonary or any other systemic diseases. Pregnant women,Patients who have not given consent for the study, patients with other respiratory ailments, patients with other atopic ailments which increases IgE level like atopic eczema,allergic rhinits.

Design outcomes

Primary

MeasureTime frame
Change in Serum IgE levels in patients with Bronchial AsthmaTimepoint: Assessed at baseline and after every 5 months.

Secondary

MeasureTime frame
To analyze the effect of homoeopathic medicine on the overall quality of life in patients with Bronchial AsthmaTimepoint: Assessed at baseline and after every 5 months.;To observe the disease relation with the potency of LM and Centesimal potency.Timepoint: Assessed at baseline and after every 5 months

Countries

India

Contacts

Public ContactDr Poonam Kakandikar

BVDUHMC

poonam.kakandikar@bharatividyapeeth.edu8623889118

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026